170
Participants
Start Date
November 30, 2002
Primary Completion Date
March 31, 2004
Study Completion Date
March 31, 2004
conivaptan
IV
placebo
IV
New York Presbyterian Hosp, Milstein Hosp., New York
Hershey Medical Center, Hershey
University of Maryland Hospital, Baltimore
Medical University of South Carolina, Charleston
Jacksonville Center for Clinical Research, Jacksonville
U. Miami, Jackson Mem'l Medical Center, Miami
The Greater Fort Lauderdale Heart Group Research, Fort Lauderdale
Discovery Medical Research Group, Ocala
The Heart Center, P.C., Huntsville
Baptist Clinical Research, Memphis
Ohio State University Medical Center, Heart and Lung Research Institute, Columbus
The Cleveland Clinic Foundation, Cleveland
University of Cincinnati, College of Medicine, Div. of Cardiology, Cincinnati
Hennepin County Medical Center, Minneapolis
Rush-Presbyterian St. Luke's Medical Center, Chicago
Washington University, St Louis
Louisiana State University Medical Center School of Medicine, New Orleans
New Orleans Center for Clinical Research, New Orleans
Cardiac Centers of Louisiana, LLC, Shreveport
Cardiovascular Research Institute of Dallas, Dallas
Baylor College of Medicine, Houston
LA County/USC Medical Center, Los Angeles
Apex Research Institute, Santa Ana
San Joaquin Cardiology, Manteca
University of Washington, Seattle
Dartmouth-Hitchcock Medical Center, Lebanon
Lead Sponsor
Cumberland Pharmaceuticals
INDUSTRY